S02.1 Treat to target in systemic lupus erythematosus from the patients’ perspective – results from an international patient survey

• M Schneider,
• J Mücke,
• I Bultink,
• A Parra Sanchez,
• D Pencheva,
• K Cramer

Affiliations

M Schneider

Department of Endocrinology, Diabetes and Rheumatology, University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany

J Mücke

1Policlinic and Hiller Research Unit for Rheumatology, Heinrich-Heine University Duesseldorf ~ Germany

I Bultink

1Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, VU University Medical Center ~ Amsterdam ~ Netherlands

A Parra Sanchez

1Amsterdam UMC, locatie AMC, Amsterdam Rheumatology Center ARC, Department of Rheumatology and Clinical Immunology, Amsterdam, the Netherlands

D Pencheva

2Department of Physiology and Pathophysiology, Medical University of Sofia ~ Bulgaria

K Cramer

4Patient Research Partner ~ Amsterdam ~ Netherlands